Prognostic value of TERF1 expression in prostate cancer.

Gabriel Arantes Dos SantosNayara Izabel VianaRuan PimentaVanessa Ribeiro GuimarãesJuliana Alves de CamargoPoliana RomãoSabrina T ReisKatia Ramos Moreira LeiteMiguel Srougi

Published in: Journal of the Egyptian National Cancer Institute (2021)

Amplification/upregulation of TERF1 was associated with the worst prognostic in localized prostate cancer. Our results corroborate that miR-155 regulates TERF1 expression in prostate cancer. TERF1 has the potential to become a biomarker in prostate cancer.

Keyphrases

prostate cancer
radical prostatectomy
poor prognosis
cell proliferation
long non coding rna
signaling pathway
risk assessment
climate change